GET THE APP

Panchakarma: A hope for LGBS Ã?¢Ã?â?¬Ã?â?? Landry Gullian Barre Syndrome Ã?¢Ã?â?¬Ã?â?? A clinical study | Abstract
international journal of bioassays.
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Panchakarma: A hope for LGBS Ã?¢Ã?â?¬Ã?â?? Landry Gullian Barre Syndrome Ã?¢Ã?â?¬Ã?â?? A clinical study

Author(s): Midhun Mohan*, Vinay Kumar K.N., Swati S. Deshpande, Kiran M. Goud

Abstract

Landry Guillain–Barré syndrome is a disorder which is caused by the body's immune system attacking its own peripheral nervous system. The syndrome afflicts about one person in 100,000. Either gender can be affected in any age group especially between ages 30 and 50, however risk increases with age. It often follows a minor infection Most of the time, signs of the original infection have disappeared before the symptoms of Guillain-Barre begin. Guillain-Barre syndrome damages parts of nerves. This nerve damage causes tingling, muscle weakness, and paralysis. Guillain-Barre syndrome most often affects the nerve's covering (myelin sheath). Such damage is called demyelination and it causes nerve signals to move more slowly. Damage to other parts of the nerve can cause the nerve to stop working altogether. It is a paralyzing syndrome which can have dire consequences if not managed by an informed medical team. This article will explain how this disorder begins, how it is managed in Ayurveda by taking help of the PANCHKARMA procedures such as basti, Abhayanga etc.

Share this article


International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.

International Journal of Bioassays [ISSN: International Journal of Bioassays] is licensed under
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© Copyright 2012-2024. All rights reserved.